Walleye Capital’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.12M | Sell |
226,015
-101,119
| -31% | -$947K | 0.01% | 613 |
|
|
2025
Q1 | $4.02M | Sell |
327,134
-37,616
| -10% | -$462K | 0.02% | 411 |
|
|
2024
Q4 | $4.82M | Buy |
364,750
+326,585
| +856% | +$4.32M | 0.01% | 443 |
|
|
2024
Q3 | $735K | Buy |
+38,165
| New | +$735K | ﹤0.01% | 1175 |
|
|
2024
Q1 | – | Sell |
-127,932
| Closed | -$2.76M | – | 2967 |
|
|
2023
Q4 | $2.76M | Buy |
+127,932
| New | +$2.76M | 0.01% | 531 |
|
|
2023
Q3 | – | Sell |
-264,464
| Closed | -$5.54M | – | 2912 |
|
|
2023
Q2 | $5.54M | Sell |
264,464
-280,626
| -51% | -$5.87M | 0.02% | 270 |
|
|
2023
Q1 | $11.5M | Buy |
545,090
+213,539
| +64% | +$4.51M | 0.17% | 118 |
|
|
2022
Q4 | $8.44M | Buy |
+331,551
| New | +$8.44M | 0.15% | 154 |
|